Meta-analysis of the association between new hypoglycemic agents and digestive diseases

New hypoglycemic agents include sodium-glucose cotransporter-2 inhibitors (SGLT2is), glucagon-like peptide 1 receptor agonists (GLP1RAs), and dipeptidyl peptidase-4 inhibitors (DPP4is). The association between each class of these new hypoglycemic drugs and the risks of various digestive system disea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medicine (Baltimore) 2022-08, Vol.101 (34), p.e30072-e30072
Hauptverfasser:	Wang, Yu-Wen, Lin, Jin-Hao, Yang, Cui-Shan
Format:	Artikel
Sprache:	eng
Schlagworte:	Systematic Review and Meta-Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	New hypoglycemic agents include sodium-glucose cotransporter-2 inhibitors (SGLT2is), glucagon-like peptide 1 receptor agonists (GLP1RAs), and dipeptidyl peptidase-4 inhibitors (DPP4is). The association between each class of these new hypoglycemic drugs and the risks of various digestive system diseases is unknown. We aimed to explore this relationship by performing a meta-analysis.
ISSN:	1536-5964 0025-7974 1536-5964
DOI:	10.1097/MD.0000000000030072